Search Results for: EGFR

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel MOB4 MOB family member 4, phocein
Novel MT-CO2 cytochrome c oxidase subunit II
  • Mitochondrial translation termination
  • TP53 Regulates Metabolic Genes
  • Respiratory electron transport
  • Cytoprotection by HMOX1
  • Mitochondrial protein degradation
  • Complex IV assembly
  • Cholic Acid
  • N-Formylmethionine
  • Talmapimod
Novel MTDH metadherin
Novel MUC1 mucin 1, cell surface associated
  • Defective GALNT3 causes HFTC
  • Defective C1GALT1C1 causes TNPS
  • Defective GALNT12 causes CRCS1
  • Dectin-2 family
  • Interleukin-4 and Interleukin-13 signaling
  • O-linked glycosylation of mucins
  • Termination of O-glycan biosynthesis
  • Developmental Lineage of Mammary Gland Luminal Epithelial Cells
  • Developmental Lineage of Mammary Gland Alveolar Cells
  • TG4010
Novel MUC4 mucin 4, cell surface associated
  • Defective GALNT3 causes HFTC
  • Defective C1GALT1C1 causes TNPS
  • Defective GALNT12 causes CRCS1
  • Dectin-2 family
  • O-linked glycosylation of mucins
  • Termination of O-glycan biosynthesis
Novel NANS N-acetylneuraminate synthase
  • Sialic acid metabolism
Novel NCAM1 neural cell adhesion molecule 1
  • ECM proteoglycans
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • NCAM1 interactions
  • NCAM1 interactions
  • Signal transduction by L1
  • RAF/MAP kinase cascade
  • Interferon gamma signaling
Novel NCK1 NCK adaptor protein 1
  • Downstream signal transduction
  • Generation of second messenger molecules
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • Nephrin family interactions
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHOU GTPase cycle
  • RHOV GTPase cycle
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Potential therapeutics for SARS
  • PKR-mediated signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
Novel NCK2 NCK adaptor protein 2
  • Downstream signal transduction
  • Nephrin family interactions
  • Ephrin signaling
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • Regulation of cortical dendrite branching
  • RHOU GTPase cycle
  • RHOV GTPase cycle
Novel NDN necdin, MAGE family member
  • Interleukin-4 and Interleukin-13 signaling
  • Prader-Willi and Angelman syndromes, including: Angelman syndrome (AS); Prader-Willi syndrome (PWS)
Novel NEDD4 NEDD4 E3 ubiquitin protein ligase
  • ISG15 antiviral mechanism
  • Downregulation of ERBB4 signaling
  • Regulation of PTEN localization
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
Novel NF2 NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
  • Regulation of actin dynamics for phagocytic cup formation
  • RHO GTPases activate PAKs
  • Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
  • Malignant pleural mesothelioma
Novel NHERF1 NHERF family PDZ scaffold protein 1
  • Nephrolithiasis/osteoporosis, hypophosphatemic
Novel NIBAN2 niban apoptosis regulator 2
Novel NR3C1 nuclear receptor subfamily 3 group C member 1
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • SUMOylation of intracellular receptors
  • PTK6 Expression
  • Regulation of RUNX2 expression and activity
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Potential therapeutics for SARS
  • Regulation of NPAS4 gene transcription
  • Flunisolide
  • Diflorasone
  • Alclometasone
  • Medrysone
  • Amcinonide
  • Fluorometholone
  • Megestrol acetate
  • Levonorgestrel
  • Beclomethasone dipropionate
  • Progesterone
  • Spironolactone
  • Betamethasone
  • Desoximetasone
  • Fluticasone propionate
  • Fluocinolone acetonide
  • Ulobetasol
  • Triamcinolone
  • Prednisone
  • Flumethasone
  • Fludrocortisone
  • Norethisterone
  • Hydrocortisone
  • Mometasone
  • Hydrocortamate
  • Mifepristone
  • Clocortolone
  • Flurandrenolide
  • Prednisolone
  • Loteprednol etabonate
  • Rimexolone
  • Methylprednisolone
  • Clobetasol propionate
  • Fluocinonide
  • Prednicarbate
  • Fluoxymesterone
  • Budesonide
  • Dexamethasone
  • Desonide
  • Cortisone acetate
  • Paramethasone
  • Drospirenone
  • Ciclesonide
  • Hexane-1,6-Diol
  • Aldosterone
  • ORG-34517
  • Difluprednate
  • Ulipristal
  • Fluticasone furoate
  • Tixocortol
  • Difluocortolone
  • Gestrinone
  • Deflazacort
  • Onapristone
  • Cortivazol
  • Clobetasone
  • Fluticasone
  • Mometasone furoate
  • Hydrocortisone aceponate
  • Hydrocortisone acetate
  • Hydrocortisone butyrate
  • Hydrocortisone cypionate
  • Hydrocortisone phosphate
  • Hydrocortisone probutate
  • Hydrocortisone valerate
  • Segesterone acetate
  • Prednisolone phosphate
  • Dexamethasone acetate
  • Betamethasone phosphate
  • Prednisolone acetate
  • 46,XX disorders of sex development (Disorders related to androgen excess), including: Congenital adrenal hyperplasias; Glucocorticoid resistance; Aromatase deficiency
Novel NRG1 neuregulin 1
  • Signaling by ERBB2
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PI3K events in ERBB4 signaling
  • SHC1 events in ERBB4 signaling
  • Nuclear signaling by ERBB4
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Downregulation of ERBB2:ERBB3 signaling
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Downregulation of ERBB2 signaling
  • Long-term potentiation
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 TMD/JMD mutants
Novel NTRK2 neurotrophic receptor tyrosine kinase 2
  • PIP3 activates AKT signaling
  • NGF-independant TRKA activation
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • BDNF activates NTRK2 (TRKB) signaling
  • NTF3 activates NTRK2 (TRKB) signaling
  • NTF4 activates NTRK2 (TRKB) signaling
  • Activated NTRK2 signals through RAS
  • Activated NTRK2 signals through PLCG1
  • Activated NTRK2 signals through PLCG1
  • Activated NTRK2 signals through PI3K
  • Activated NTRK2 signals through FRS2 and FRS3
  • Activated NTRK2 signals through FRS2 and FRS3
  • Activated NTRK2 signals through FYN
  • NTRK2 activates RAC1
  • NTRK2 activates RAC1
  • Activated NTRK2 signals through CDK5
  • Amitriptyline
  • Esketamine
  • Entrectinib
  • Fostamatinib
  • Larotrectinib
  • Neuroblastoma
Novel NUMB NUMB endocytic adaptor protein
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Recycling pathway of L1
  • Degradation of GLI1 by the proteasome
  • Hedgehog 'on' state
  • Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
Novel NUMBL NUMB like endocytic adaptor protein
Novel OAZ1 ornithine decarboxylase antizyme 1
  • Regulation of ornithine decarboxylase (ODC)
  • Metabolism of polyamines
  • Ornithine

Page 11 out of 42 pages